Novavax submitted its emergency use authorization on January 31, and there has been no meeting scheduled of the FDA's advisory committee.
By comparison, Pfizer/BioNTech's meeting was scheduled on December 10, 2020, after filing on November 20. Moderna's (MRNA) meeting was scheduled on December...